Aditya Birla Sun Life Pharma & Healthcare Fund
An open ended equity scheme investing in Pharma and Healthcare Services Sector
May 2026
| Equity Scheme |  |
 |
 |
 |
An open ended equity scheme investing in Pharma and Healthcare Services Sector
May 2026
| Equity Scheme | |
|
|
|
| Investment Objective | |
| The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There is no assurance that the objective of the Scheme will be achieved | |
| Fund Category: Sectoral/Thematic | |
 |
|
| Fund Snapshot | |
| Date of Allotment : Jul 11, 2019 | |
| Benchmark: BSE Healthcare TRI | |
| Fund Manager -Mr. Dhaval Shah Managing the Fund Since: July 11, 2019 Experience in Managing the Fund: 6.9 Years |
|
| SIP: Daily/Weekly/Monthly: Minimum ₹ 100/-and in multiples of ₹ 1/- thereafter |
|
| Application Amount for fresh subscription: ₹ 1000 (plus in multiplies of ₹ 1) |
|
| Minimum Additional Investment: ₹ 1000 (plus in multiplies of ₹ 1) |
|
| Load Structure (as % of NAV) (Incl. for SIP) | |
| Entry Load: | NIL |
| Exit Load: | For redemption/switch-out of units on or before 30 days from the date of allotment:1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil |
| Count of Securities: 38 | |
| AUM as on May 31, 2026 (in ₹Crore) | |
| Month End AUM | 950.31 |
| Monthly Average AUM | 946.53 |
| Base Expense Ratio (BER) | |
| Regular | 1.94% |
| Direct | 0.84% |
| BER excludes brokerage incurred towards execution of trades, transaction cost & statutory levies as applicable to investors. | |
| NAV as on May 29, 2026 | |
| Regular Growth | 33.04 |
| Regular IDCW$ | 21.82 |
| Direct Growth | 36.70 |
| Direct IDCW$ | 23.86 |
| $Income Distribution cum capital withdrawal | |
| Valuation Parameters | |
| Average P/E | 40.47 |
| Average P/BV | 6.08 |
| Average Dividend Yield | 0.78% |
| Sectoral Contribution(in %) |
 |
| Market Capitalisation |
 |
| Volatility Measures | |
| Portfolio Turnover | 0.22 |
| Standard Deviation | 16.13% |
| Sharpe Ratio | 1.13 |
| Beta | 0.92 |
| Treynor Ratio | 0.20 |
| Information Ratio | -0.49 |
Note: Standard Deviation, Sharpe Ratio & Beta are calculated on Annualised basis using 3 years history of monthly returns. Risk FreeRate assumed tobe 5.52%(FBIL OvernightMIBOR as on 29 May, 2026) for calculating SharpeRatio
| Rating Profile of Portfolio |  |
| Sector/Issuer Name | % of Net AUM |
| Equity & Equity Related | |
| Pharmaceuticals & Biotechnology | 75.07% |
| Sun Pharmaceutical Industries Limited | 12.42% |
| Torrent Pharmaceuticals Limited | 4.75% |
| J.B. Chemicals & Pharmaceuticals Limited | 4.73% |
| Aurobindo Pharma Limited | 4.37% |
| Ajanta Pharmaceuticals Limited | 3.99% |
| Mankind Pharma Ltd | 3.89% |
| Lupin Limited | 3.73% |
| Abbott India Limited | 3.65% |
| Emcure Pharmaceuticals Ltd | 3.17% |
| Cipla Limited | 2.98% |
| Shilpa Medicare Ltd | 2.92% |
| IPCA Laboratories Limited | 2.43% |
| SAI Life Sciences Ltd | 2.26% |
| Procter & Gamble Health Limited | 2.24% |
| CORONA Remedies Ltd | 2.06% |
| Alkem Laboratories Limited | 2.03% |
| Divi's Laboratories Limited | 1.82% |
| SANOFI CONSUMER HEALTHCARE | 1.52% |
| Pfizer Limited | 1.36% |
| Dr. Reddys Laboratories Limited | 1.36% |
| ALEMBIC PHARMACEUTICALS LIMITED | 1.25% |
| Biocon Limited | 1.23% |
| Gland Pharma Limited | 1.20% |
| Piramal Pharma Ltd | 1.16% |
| ANTHEM BIOSCIENCES LIMITED | 1.13% |
| GlaxoSmithKline Pharmaceuticals Limited | 0.75% |
| Jubilant Pharmova Ltd | 0.66% |
| Healthcare Services | 20.09% |
| Apollo Hospitals Enterprise Limited | 7.31% |
| Fortis Healthcare Limited | 3.31% |
| Thyrocare Technologies Limited | 1.89% |
| Jupiter Life Line Hospitals Ltd | 1.84% |
| METROPOLIS HEALTHCARE LIMITED | 1.57% |
| Dr. Lal Path Labs Limited | 1.38% |
| Vijaya Diagnostic Centre Limited | 1.08% |
| Suraksha Diagnostic Ltd | 1.01% |
| Max Healthcare Institute Limited | 0.71% |
| Insurance | 1.01% |
| Medi Assist Healthcare Services Ltd | 1.01% |
| Chemicals & Petrochemicals | 0.65% |
| Vinati Organics Limited | 0.65% |
| Cash & Current Assets | 3.17% |
| Grand Total | 100.00% |
Miscellaneous includes securities with exposure of less than 0.01%
| Scheme Name | |
| Aditya Birla Sun Life Pharma & Healthcare Fund An open ended equity scheme investing in Pharma and Healthcare Services Sector |
|
| This product is suitable for investors who are seeking*: | |
|
|
Risk-o-meter  |
Benchmark Risk-o-meter BSE Healthcare TRI  |
| *Investors should consult their financial advisors if in doubt whether the product is suitable for them. | |